Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ganzina

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Minerva Medica|October 13, 1970
[Action of a new synthetic drug, chlorocamphamide, on experimental ulcer and on gastric secretion in the rat]F Ganzina
Cancer Treatment Reviews|March 1, 1983
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataF Ganzina
Tumori|October 31, 1979
High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A reviewF Ganzina
Acta Gastro-Enterologica Belgica|May 1, 1976
Caerulein (ceruletide). A reviewF Ganzina, A Santamaria
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicinP Hurteloup, F Ganzina
Arzneimittel-Forschung|August 1, 1973
Effects of 2-N-(p-chlorobenzoyl)-N-(2-hydroxyethyl)aminomethyl-3-methyl-norbornane on ganglionic transmission and response to acetylcholine and pilocarpineG C Pantaleoni, F Ganzina
Tumori|June 30, 1985
Clinical toxicity of 4'-epi-doxorubicin (epirubicin)F Ganzina, N Di Pietro, O Magni
Il Farmaco; Edizione Scientifica|August 1, 1970
[Norbornanomethylamine amides. I. Synthesis and properties of amides from 2-aminomethyl-3-methylnorbornane]D Antoniu, F Ganzina, M Magi, et al.
Investigational New Drugs|January 1, 1986
Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studiesF Ganzina, M A Pacciarini, N Di Pietro
Haematologica|March 1, 1990
Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studiesA M Carella, E Berman, M P Maraone, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Minerva Medica|October 13, 1970
[Action of a new synthetic drug, chlorocamphamide, on experimental ulcer and on gastric secretion in the rat]F Ganzina
Cancer Treatment Reviews|March 1, 1983
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataF Ganzina
Tumori|October 31, 1979
High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A reviewF Ganzina
Acta Gastro-Enterologica Belgica|May 1, 1976
Caerulein (ceruletide). A reviewF Ganzina, A Santamaria
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicinP Hurteloup, F Ganzina
Arzneimittel-Forschung|August 1, 1973
Effects of 2-N-(p-chlorobenzoyl)-N-(2-hydroxyethyl)aminomethyl-3-methyl-norbornane on ganglionic transmission and response to acetylcholine and pilocarpineG C Pantaleoni, F Ganzina
Tumori|June 30, 1985
Clinical toxicity of 4'-epi-doxorubicin (epirubicin)F Ganzina, N Di Pietro, O Magni
Il Farmaco; Edizione Scientifica|August 1, 1970
[Norbornanomethylamine amides. I. Synthesis and properties of amides from 2-aminomethyl-3-methylnorbornane]D Antoniu, F Ganzina, M Magi, et al.
Investigational New Drugs|January 1, 1986
Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studiesF Ganzina, M A Pacciarini, N Di Pietro
Haematologica|March 1, 1990
Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studiesA M Carella, E Berman, M P Maraone, et al.
Pageof 3